SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-24-000120
Filing Date
2024-09-18
Accepted
2024-09-18 11:01:27
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM-10Q form-10q.htm   iXBRL 10-Q 378352
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO exhibit31-1.htm EX-31.1 7269
3 CERTIFICATION exhibit32-1.htm EX-32.1 3235
  Complete submission text file 0001826466-24-000120.txt   2363229

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nkph-20240630.xsd EX-101.SCH 20011
5 XBRL CALCULATION FILE nkph-20240630_cal.xml EX-101.CAL 32087
6 XBRL DEFINITION FILE nkph-20240630_def.xml EX-101.DEF 81336
7 XBRL LABEL FILE nkph-20240630_lab.xml EX-101.LAB 177625
8 XBRL PRESENTATION FILE nkph-20240630_pre.xml EX-101.PRE 154737
51 EXTRACTED XBRL INSTANCE DOCUMENT form-10q_htm.xml XML 206617
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

IRS No.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 241306480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)